Catalog #
  • ---All---
  • Accession
  • Catalog #

VEGFC antibody ( Ascites)Mouse Monoclonal Antibody (Mab)

Country
United States
Albania Australia Austria Belgium Bosnia & Herzegovina Brazil Bulgaria Canada China Croatia Cyprus Czech Republic Denmark Estonia Finland France Germany Greece Hong Kong Hungary Iceland India Indonesia Ireland Israel Italy Japan Korea Latvia Lithuania Luxembourg Macedonia Malaysia Malta Netherlands New Zealand Norway Pakistan Poland Portugal Romania Serbia Singapore Slovakia Slovenia South Africa Spain Sweden Switzerland Taiwan Turkey United Kingdom United States Vietnam Others
Ordering Information
Catalog # Size Availability Price  
AM1886a 0.1 ml In Stock $ 265.00 Add to cart
  • Specification
  • Citations : 0
  • Reviews
  • Protocols
  • Background

VEGFC antibody ( Ascites) - Product info

ApplicationWB
  • Applications Legend:
  • WB=Western Blotting
  • IP=Immunoprecipitation
  • IHC-P=Immunohistochemistry (Paraffin)
  • IF-IC=Immunofluorescence (Immunocytochemistry)
  • FC=Flow Cytometry
  • DB=Dot Blot
Primary AccessionP49767
ReactivityHuman
IsotypeIgG1,IGK
Clone Names197CT7.3.4
Calculated MW46883 Da

VEGFC antibody ( Ascites) - Additional info

Gene ID 7424
Other Names
VEGFC; Vascular endothelial growth factor C; Flt4 ligand; Vascular endothelial growth factor-related protein
Target/Specificity
This VEGFC monoclonal antibody is generated from mouse immunized with VEGFC recombinant protein.
Dilution
WB~~1:1000~8000
Format
Mouse monoclonal antibody supplied in crude ascites with 0.09% (W/V) sodium azide.
Storage
Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Precautions
VEGFC antibody ( Ascites) is for research use only and not for use in diagnostic or therapeutic procedures.

VEGFC antibody ( Ascites) - Protein Information

Name VEGFC
Function
Growth factor active in angiogenesis, and endothelial cell growth, stimulating their proliferation and migration and also has effects on the permeability of blood vessels. May function in angiogenesis of the venous and lymphatic vascular systems during embryogenesis, and also in the maintenance of differentiated lymphatic endothelium in adults. Binds and activates VEGFR-2 (KDR/FLK1) and VEGFR-3 (FLT4) receptors.
Cellular Location
Secreted.
Tissue Location
Spleen, lymph node, thymus, appendix, bone marrow, heart, placenta, ovary, skeletal muscle, prostate, testis, colon and small intestine and fetal liver, lung and kidney, but not in peripheral blood lymphocyte

VEGFC antibody ( Ascites) - Related products

AM1100a: VEGF3 Antibody

AM1886b: VEGFC Antibody

AP11951a: VEGF3 Antibody (N-term)

AP2042c: VEGFC (VEGF3) Antibody (Center M263)

AP2042d: VEGFC Antibody

BP11951a: VEGF3 Antibody (N-term) Blocking Peptides

BP2042c: VEGF3 Antibody (Center M263) Blocking Peptide

VEGFC antibody ( Ascites) - Application data

  • VEGFC (Cat. #AM1886a) western blot analysis in HepG2 cell line lysates (35ug/lane).This demonstrates the VEGFC antibody detected the VEGFC protein (arrow).

VEGFC antibody ( Ascites) - Research Areas

AntibodiesGene OntologyBiological ProcessCell DifferentiationEmbryonic DevelopmentNeurogenesisOrgan DevelopmentSignal TransductionTissue DevelopmentCellular ProcessPositive Regulation Of Biological ProcessPositive Regulation Of Cellular ProcessPositive Regulation Of Cellular Metabolic ProcessPositive Regulation Of Metabolic ProcessPositive Regulation Of Macromolecule Metabolic ProcessRegulation Of PhosphorylationRegulation Of Phosphate Metabolic ProcessRegulation Of Phosphorus Metabolic ProcessSystem DevelopmentMulticellular Organismal DevelopmentAnatomical Structure DevelopmentRegulation Of Cell ProliferationEnzyme Linked Receptor Protein Signaling PathwayRegulation Of Protein Metabolic ProcessRegulation Of Protein Amino Acid PhosphorylationRegulation Of Protein Modification ProcessRegulation Of Cellular Protein Metabolic ProcessDevelopmental ProcessPositive Regulation Of Cell ProliferationAnatomical Structure MorphogenesisPositive Regulation Of Protein Metabolic ProcessTransmembrane Receptor Protein Tyrosine Kinase Signaling PathwayPositive Regulation Of Cellular Protein Metabolic ProcessVasculature DevelopmentBlood Vessel DevelopmentRegulation Of Multicellular Organismal ProcessBlood Vessel MorphogenesisOrgan MorphogenesisPositive Regulation Of Protein Modification ProcessCell ProliferationAngiogenesisNervous System DevelopmentRegulation Of LocalizationRegulation Of TransportPositive Regulation Of TransportPositive Regulation Of PhosphorylationGeneration Of NeuronsRegulation Of Metabolic ProcessRegulation Of Developmental ProcessPositive Regulation Of Developmental ProcessCellular Developmental ProcessPositive Regulation Of Phosphate Metabolic ProcessPositive Regulation Of Phosphorus Metabolic ProcessRegulation Of Cellular Metabolic ProcessPositive Regulation Of Protein Amino Acid PhosphorylationRegulation Of Cell DifferentiationPositive Regulation Of Cell MotionAnatomical Structure Formation Involved In MorphogenesisCell MotionBiological RegulationPositive Regulation Of LocomotionRegulation Of Cell MotionRegulation Of Macromolecule Metabolic ProcessRegulation Of Cellular LocalizationRegulation Of SecretionPositive Regulation Of Cell MigrationPositive Regulation Of Cell DivisionRegulation Of Cell MigrationRegulation Of Epithelial Cell ProliferationRegulation Of Primary Metabolic ProcessPositive Regulation Of Protein TransportPositive Regulation Of Cell DifferentiationRegulation Of Biological ProcessRegulation Of LocomotionRegulation Of Cell DivisionMulticellular Organismal ProcessCell MigrationRegulation Of Establishment Of Protein LocalizationPositive Regulation Of SecretionRegulation Of Cellular ProcessPositive Regulation Of Epithelial Cell ProliferationCell MotilityLocalization Of CellRegulation Of Endothelial Cell MigrationRegulation Of Protein TransportRegulation Of Protein LocalizationRegulation Of Cell DevelopmentEmbryonic MorphogenesisRegulation Of Blood Vessel Endothelial Cell MigrationVascular Endothelial Growth Factor Receptor Signaling PathwayPositive Regulation Of Protein SecretionPositive Regulation Of Cell DevelopmentCellular CompartmentCytoplasmExtracellular SpaceIntracellular PartIntracellularCytoplasmic PartMembrane-bounded OrganelleIntracellular Membrane-bounded OrganelleMembrane-enclosed LumenOrganelle LumenOrganelleIntracellular OrganelleOrganelle PartIntracellular Organelle PartVesicleCytoplasmic Membrane-bounded Vesicle LumenMembrane-bounded VesicleCytoplasmic Vesicle PartVesicle LumenPlatelet Alpha Granule LumenCytoplasmic VesicleCytoplasmic Membrane-bounded VesicleExtracellular Region PartPlatelet Alpha GranuleSecretory GranuleMolecular FunctionProtein BindingGrowth Factor ActivityReceptor BindingPathwaysKEGGPancreatic CancerRenal Cell CarcinomaPathways In CancerMTOR Signaling PathwayBladder CancerTissueSkinUrinary Bladder

Abgent welcomes feedback from its customers.

If you have used an Abgent product and would like to share how it has performed, please click on the
"Submit Review" button and provide the requested information. Our staff will examine and post your
review and contact you if needed.

If you have any additional inquiries please email technical services at tech@abgent.com.

Thank you for your support.


Submit

Provided below are standard protocols that you may find useful for product applications.

BACKGROUND

The protein encoded by this gene is a member of the platelet-derived growth factor/vascular endothelial growth factor (PDGF/VEGF) family, is active in angiogenesis and endothelial cell growth, and can also affect the permeability of blood vessels. This secreted protein undergoes a complex proteolytic maturation, generating multiple processed forms which bind and activate VEGFR-3 receptors. Only the fully processed form can bind and activate VEGFR-2 receptors. This protein is structurally and functionally similar to vascular endothelial growth factor D. [provided by RefSeq].

REFERENCES

Chen, X., et al. Cancer Sci. 101(11):2384-2390(2010)
Romero, R., et al. Am. J. Obstet. Gynecol. 203 (4), 361 (2010) :
Bailey, S.D., et al. Diabetes Care 33(10):2250-2253(2010)
Deguchi, K., et al. Anticancer Res. 30(6):2361-2366(2010)
Johnatty, S.E., et al. PLoS Genet. 6 (7), E1001016 (2010) :